论文部分内容阅读
癫痫的患病率为5‰～10‰,而大约50％的癫痫病人的发作不能被充分控制或有明显的药物不良反应,如嗜睡、共济失调、注意力分散等。各种非药物治疗手段在迷走神经刺激术(Vagus Nerve Stimulation VNS)之前已在临床应用。这些治疗包括癫痫外科、小脑刺激术、丘脑刺激术等,但是并非所有患者均适合应用这些治疗方法。左侧迷走神经刺激术是近年来受到关注的治疗癫痫新方法,在动物试验基础上通过埋藏在颈部的植入性神经控制辅助系统(Neurocybernetic Prosthesis,NCP)发出电信号刺激迷走神经以治疗癫痫,其副作用可以通过调整刺激发生器得到控制,该治疗对于成年人癫痫中复杂的部分性发作有明显控制效果。至1997年6月,世界范围内已有1000人以
The prevalence of epilepsy is 5 ‰ ~ 10 ‰, and about 50% of epilepsy patients can not be adequately controlled or have obvious adverse drug reactions such as lethargy, ataxia, distractions and so on. A variety of non-drug treatments have been used clinically prior to vagal nerve stimulation (Vagus Nerve Stimulation VNS). These treatments include epilepsy surgery, cerebellar stimulation, thalamic stimulation, etc., but not all patients are suitable for the application of these treatments. The left vagus nerve stimulation is a new method of treating epilepsy that has been paid attention in recent years. Based on the animal experiment, the vagus nerve is stimulated by buried neurosurgical prosthesis (NCP) in the neck to treat the epilepsy. Side effects can be controlled by adjusting the stimulation generator, which has significant control over the complex, partial seizures in adults with epilepsy. By June 1997, there were already 1,000 people in the world